Premium
Real‐time characterization of cannabinoid receptor 1 ( CB 1 ) allosteric modulators reveals novel mechanism of action
Author(s) -
Cawston Erin E,
Redmond William J,
Breen Courtney M,
Grimsey Natasha L,
Connor Mark,
Glass Michelle
Publication year - 2013
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/bph.12329
Subject(s) - allosteric regulation , allosteric modulator , chemistry , agonist , internalization , receptor , mechanism of action , biophysics , pharmacology , stereochemistry , biochemistry , biology , in vitro
Background and Purpose The cannabinoid receptor type 1 ( CB 1 ) has an allosteric binding site. The drugs ORG 27569 {5‐chloro‐3‐ethyl‐ N ‐[2‐[4‐(1‐piperidinyl)phenyl]ethyl]‐1 H ‐indole‐2‐carboxamide} and PSNCBAM ‐1 {1‐(4‐chlorophenyl)‐3‐[3‐(6‐pyrrolidin‐1‐ylpyridin‐2‐yl)phenyl]urea} have been extensively characterized with regard to their effects on signalling of the orthosteric ligand CP 55,940 {(−)‐ cis ‐3‐[2‐hydroxy‐4‐(1,1‐dimethylheptyl)phenyl]‐ trans ‐4‐(3‐hydroxypropyl)cyclohexanol}, and studies have suggested that these allosteric modulators increase binding affinity but act as non‐competitive antagonists in functional assays. To gain a deeper understanding of allosteric modulation of CB 1 , we examined real‐time signalling and trafficking responses of the receptor in the presence of allosteric modulators. Experimental Approach Studies of CB 1 signalling were carried out in HEK 293 and AtT20 cells expressing haemagglutinin‐tagged human and rat CB 1 . We measured real‐time accumulation of cAMP , activation and desensitization of potassium channel‐mediated cellular hyperpolarization and CB 1 internalization. Key Results ORG 27569 and PSNCBAM ‐1 produce a complex, concentration and time‐dependent modulation of agonist‐mediated regulation of cAMP levels, as well as an increased rate of desensitization of CB 1 ‐mediated cellular hyperpolarization and a decrease in agonist‐induced receptor internalization. Conclusions and Implications Contrary to previous studies characterizing allosteric modulators at CB 1, this study suggests that the mechanism of action is not non‐competitive antagonism of signalling, but rather that enhanced binding results in an increased rate of receptor desensitization and reduced internalization, which results in time‐dependent modulation of cAMP signalling. The observed effect of the allosteric modulators is therefore dependent on the time frame over which the signalling response occurs. This finding may have important consequences for the potential therapeutic application of these compounds.